APA

Lerner S. P., Tangen C. M., Sucharew H., Wood D. & Crawford E. D. (20090701). Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer. : Urologic oncology.

Chicago

Lerner Seth P, Tangen Catherine M, Sucharew Heidi, Wood David and Crawford E David. 20090701. Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer. : Urologic oncology.

Harvard

Lerner S. P., Tangen C. M., Sucharew H., Wood D. and Crawford E. D. (20090701). Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer. : Urologic oncology.

MLA

Lerner Seth P, Tangen Catherine M, Sucharew Heidi, Wood David and Crawford E David. Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer. : Urologic oncology. 20090701.